4Filed Jul 19, 8:00 PM ET

JFrog (FROG) Director Sela Yossi Sells 25,000 Shares

$FROG · JFrog Ltd

Research Summary

AI-generated summary of this SEC filing

Updated

JFrog (FROG) Director Sela Yossi Sells 25,000 Shares

What Happened

  • Sela Yossi, a director of JFrog Ltd. (FROG), sold a total of 25,000 shares in open-market transactions on July 16, 2026, generating approximately $2,185,743 in proceeds. The sales were reported on a Form 4 filed July 20, 2026.
  • Breakdown of the four reported sales:
    • 8,001 shares at $86.49 — $692,006
    • 11,923 shares at $87.58 — $1,044,216
    • 4,576 shares at $88.44 — $404,701
    • 500 shares at $89.64 — $44,820
  • These are sales (S) — routine insider selling rather than purchases (which can signal buy-side confidence).

Key Details

  • Transaction date: July 16, 2026; Form 4 filed July 20, 2026 (filed on the expected deadline, not late).
  • Total shares sold: 25,000; total proceeds: ~$2.19 million.
  • Footnotes:
    • F1: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted Sept 5, 2025 (prearranged plan).
    • F2–F5: Each reported price is a weighted average; individual trades within each group ranged approximately:
      • F2: $86.13–$87.12 (avg $86.49)
      • F3: $87.13–$88.12 (avg $87.58)
      • F4: $88.13–$89.04 (avg $88.44)
      • F5: $89.16–$90.11 (avg $89.64)
  • Shares owned after the transactions: Not included in the provided excerpt — check the full Form 4 for post-sale holdings.

Context

  • Sales done under a 10b5-1 plan are pre-scheduled and are common for insiders to systematically sell shares; they don’t necessarily reflect a change in insider sentiment.
  • For retail investors, purchases are generally more informative as positive signals; these are routine sales under a trading plan and should be interpreted accordingly.
  • If you want exact per-trade timestamps or the number of shares at each specific price, the filer states they will provide that information upon request to the SEC staff, the issuer, or a security holder.